AGTC files IND for X-linked retinitis pigmentosa treatment

09:39 EDT 10 Aug 2017 | CentreWatch

Applied Genetic Technologies, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, has filed an Investigational New Drug application (IND) with the FDA to conduct a phase I/II clinical trial of the company’s gene therapy product candidate for the treatment of X-linked retinitis pigmentosa (XLRP) […]

The post AGTC files IND for X-linked retinitis pigmentosa treatment appeared first on CenterWatch News Online.

Original Article: AGTC files IND for X-linked retinitis pigmentosa treatment


More From BioPortfolio on "AGTC files IND for X-linked retinitis pigmentosa treatment"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...